ProShare Advisors
NBP

ProShare Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

ProShare Advisors’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,553
Closed -$311K – 2248
2021
Q4 		$311K Sell
6,553
-2,401
-27% -$144K ﹤0.01% 1764
2021
Q3 		$649K Buy
8,954
+3,219
+56% +$233K ﹤0.01% 1061
2021
Q2 		$481K Buy
+5,735
New +$378K ﹤0.01% 1569

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ProShare Advisors's NBP Position: Q1 2022 in Review

ProShare Advisors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 6,553 shares — an estimated $311K sold.

ProShare Advisors first reported a position in NBP in Q2 2021 and held it in 3 quarters. The position peaked at $649K in Q3 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • ProShare Advisors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • ProShare Advisors sold 6,553 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $311K.
  • ProShare Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 3 quarters.
  • ProShare Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $649K in Q3 2021.
  • 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.